Is Bortezomib a Rare Cause of Acute Pancreatitis?

Authors

  • Tevfik Solakoglu Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Mustafa Akar Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Tugba Aktan Kosker Department of Internal Medicine, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Semnur Buyukasik Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Osman Ersoy Department of Gastroenterology, Yildirim Beyazit University, Faculty of Medicine. Ankara, Turkey

DOI:

https://doi.org/10.6092/1590-8577/1927

Keywords:

bortezomib, Multiple Myeloma, Pancreatitis, Acute Necrotizing

Abstract

No abstract available.

Image: Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16). (From Wikimedia Commons).

Downloads

Download data is not yet available.

Author Biographies

Tevfik Solakoglu, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey

Department of Gastroenterology

Mustafa Akar, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey

Department of Gastroenterology

Tugba Aktan Kosker, Department of Internal Medicine, Ankara Ataturk Education and Research Hospital. Ankara, Turkey

Department of Internal Medicine

Semnur Buyukasik, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey

Department of Gastroenterology

Osman Ersoy, Department of Gastroenterology, Yildirim Beyazit University, Faculty of Medicine. Ankara, Turkey

Department of Gastroenterology

References

Elouni B, Ben Salem C, Zamy M, Sakhri J, Bouraoui K, Biour M. Bortezomib-induced acute pancreatitis (Letter). JOP. J pancreas (Online) 2010; 11:275-6.

Kane RC, Bross PF, Farrell AT, Pazdur R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist. 2003;8:508-13.

Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143-55.

Mihaila RG. A possible rare complication of bortezomib treatment: acute pancreatitis. Acta Medica Transilvanica 2013; 2:269-71.

Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16).

Downloads

Published

2013-11-10

How to Cite

Solakoglu, T., Akar, M., Aktan Kosker, T., Buyukasik, S., & Ersoy, O. (2013). Is Bortezomib a Rare Cause of Acute Pancreatitis?. JOP. Journal of the Pancreas, 14(6), 682–683. https://doi.org/10.6092/1590-8577/1927

Issue

Vol. 14 No. 6 (2013): November - p. 603-693

Section

LETTERS

License

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.